Antigenix Therapeutics

StrongNo broker found

Relationship-build now — graduating BioLabs in 12-18 months as they advance to IND filing

Website ↗LinkedIn ↗

Company Info

Industry: Biotech / ADC Oncology
Location: Princeton, NJ (incubator)
Employees: 15+30.0%

Office Situation

Address: Princeton Innovation Center BioLabs, 303A College Road East, Suite A, Princeton, NJ 08540
Current Space: Shared incubator bench space (BioLabs)
Lease Expiry: N/A (flexible incubator)

Funding

Total Raised: $7M seed
Last Round: $7M Seed
Round Date: Dec 1, 2025

Decision Makers

Squire ServancePrimary3rd

Managing Partner, Syridex Bio (parent venture studio)

Princeton, NJ

Duke JD/MBA. Previously SVP/GC at Repligen. Local Princeton decision maker for space.

Christopher C. WhitfieldN/A

CEO

Indianapolis, IN

Remote CEO. 25+ years biopharma exec. YPO member.

Qualification

ADC oncology startup at Princeton BioLabs incubator. $7M seed (Dec 2025) with NJEDA participation. Advancing toward IND filing. CEO is remote (Indianapolis) but Squire Servance (Syridex Bio founder/managing partner) is Princeton-based and is the local decision maker. Will outgrow BioLabs when they start GLP tox studies. Long-term play (12-18 months).

Broker Intel

No broker found

Currently in BioLabs incubator — no independent lease. Will need own space when graduating (est. 12-18 months).

Warm Intro Paths

📍
Squire Servance lives in Princeton — local and accessibleLinkedIn ↗
🏢
Same building as ArrePath (303A College Road East) — door-knock bothBioLabs LinkedIn ↗
📅
Medlantic at BioLabs (Jul 14, 2026) — MedTech showcase at their incubatorCooper Health ↗
🏛️
NJEDA participated in seed round — shared NJ ecosystemAntigenix ↗

Sources

Claim	Source
At Princeton Innovation Center BioLabs	BioLabs LinkedIn post ↗
$7M seed (Dec 2025), Pier70 Ventures led, NJEDA participated	Press release ↗
Squire Servance is Princeton-based Syridex Bio founder	LinkedIn ↗
CEO Christopher Whitfield is in Indianapolis	LinkedIn ↗

Events & Touchpoints

Medlantic at BioLabsJul 14, 2026
Princeton Innovation Center BioLabsMedTech showcase at Antigenix's incubator

Draft Outreach Message

Hi Squire — Congrats on Antigenix's launch and the $7M seed! As the Syridex portfolio grows and Antigenix advances toward IND, there'll come a time when the BioLabs space isn't enough. I work with Adam Englander at CBRE — we help early-stage biotechs plan their "graduation" from incubator to dedicated lab/office space in the Princeton corridor. Happy to be a resource when that time comes. — Carly